Screener
Ginkgo Bioworks DNA Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Concentration risk by Product | ||||||
| Agriculture | 20%-3.0pp | 13%-28.0pp | —— | 29%+18.0pp | 23%0.0pp | |
| Industrial and environment | 2%-2.0pp | 0%-1.0pp | 3%— | 3%+2.0pp | 4%-11.0pp | |
| Food and nutrition | 7%+1.0pp | 7%+3.0pp | —— | 3%-61.0pp | 6%+2.0pp | |
| Government and defense | 45%+24.0pp | 35%+19.0pp | 1%— | 29%+22.0pp | 21%-4.0pp | |
| Consumer and technology | 6%+4.0pp | 7%0.0pp | —— | 3%0.0pp | 2%-9.0pp | |
| Pharmaceutical and biotechnology | 20%-24.0pp | 38%+7.0pp | —— | 33%+19.0pp | 44%+22.0pp | |
| Concentration risk by Geography | ||||||
| UNITED STATES | 83%+4.0pp | 66%-15.0pp | —— | 76%-13.0pp | 79%-5.0pp |
FAQ
- How does Ginkgo Bioworks break its business down?
- Ginkgo Bioworks (DNA) reports concentration risk percentage by business across 2 parts — Biosecurity and Cell Engineering. Each is extracted from the segment footnotes and tracked over time.
- Where does Ginkgo Bioworks's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Ginkgo Bioworks's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
